Minute Insights
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Minute Insight: Abbott Teams Up With WeightWatchers In Diabetes Management
The companies will link Abbott’s blood glucose monitoring devices to WeightWatchers’ smartphone apps and weight loss program.
Minute Insight: NeuroOne Amends Deal With Zimmer Biomet To Shore Up Balance Sheet
Zimmer Biomet agreed to amend its exclusive development and distribution agreement with NeuroOne to pay $3.5m for 350,000 of stock. The deal will help NeuroOne continue to develop its Evo stereoelectroencephalography brain-mapping electrodes without further diluting the company’s stock.
Minute Insight: Novartis, Medtronic, NHS Trust And RYSE Join Forces To Spur Development Of Digital Heart Health Solutions
Novartis Biome UK Heart Health Catalyst is taking applications from start-ups, researchers and technologists through 31 August. As much as £3m is up for grabs and specific interest in non-invasive lipid measurement techniques and at-home blood pressure testing using software as a medical device.
Minute Insight: Acutus Adds Another Device To The Left-Heart Business It Sold To Medtronic
The company announced the US launch of the AcQCross Qx transseptal dilator/needle. It is specifically designed to help deploy Boston Scientific’s Watchman left-atrial appendage closure device, but it is part of the left-heart access device portfolio that Acutus recently sold to Medtronic.
Minute Insight: Abbott Plans Move Into Famous Chicago Skyscraper
Local newspapers in Chicago confirm that Abbott is leasing space in Chicago’s most famous building in an attempt to better serve employees who live closer to the city than its Lake County, IL, campus.
Minute Insight: Abbott Is Planning To Combine Glucose And Ketone Measurement Into One Wearable
The company announced that it is developing a new biowearable device that will continuously monitor both glucose and ketone levels with one sensor.
Minute Insight: Abbott Touts 14-Day FreeStyle Libre 3 Data
Shortly after the FDA approved Abbott's FreeStyle Libre 3 continuous glucose monitor system, the company announced new clinical data showing that it is the most accurate 14-day CGM system available.
Minute Insight: Real-World Data Supports Medtronic’s 780G Insulin Pump
Postmarket data from Europe and Chile, announced at the American Diabetes Association conference, offer more support for Medtronic’s faith in its MiniMed 780G system with the Guardian 4 sensor.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.